Clinical Trial Readiness for the Dystroglycanopathies

Abroad (travel likely)Recruiting

Conditions

Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Iowa, 200 Hawkins Drive, Iowa City, Iowa, United States
Contact: Study coordinator (Carrie Stephan, R.N. M.A.) · (319)356-2673

Study leads

Katherine Mathews, M.D.
Principal Investigator
University of Iowa
Kevin Campbell, Ph.D.
Study Director
Co-Investigator
Steven A. Moore, M.D. Ph.D.
Study Director
Co-Investigator

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE3

Little Rock, United States · Flower Mound, United States

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Little Rock, United States · Los Angeles, United States

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

Duchene Muscular Dystrophy

Abroad (travel likely)Recruiting

Little Rock, United States · Washington D.C., United States

AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Little Rock, United States · Palo Alto, United States